Episode 40 - On The Wards: The Antibodies of Wrath | IVIG and Rituximab Reactions
Bloody Minded
00:00
IVIG and Rituximab Insights
This chapter explores the use of Intravenous Immunoglobulin (IVIG) to manage low antibody levels and autoimmune disorders, emphasizing administration protocols and potential side effects. It also highlights the monoclonal antibody rituximab, detailing its hybrid makeup, therapeutic applications in B-cell malignancies, and the humorous complexities of antibody naming conventions. Additionally, the chapter discusses significant clinical outcomes related to rituximab in various hematological and autoimmune conditions.
Transcript
Play full episode
